Notify me when Laura Natalia Monica Fonda files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TLSA | Tiziana Life Sciences Ltd | Common | 5.7% | 6,805,556 | LAURA NATALIA MONICA FONDA | 12 Sep 2025 | |||
| OKYO | OKYO Pharma Ltd | Common | 5% | $3,856,902 | 1,928,451 | LAURA NATALIA MONICA FONDA | 22 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|